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General  Characteristics  (n=70) 
men/women (n) 43/27 
Age (y) 56±11.5 
BMI (kg/m2) 25.8±4.7 
Diabetes 19(27%) 
Current smokers 9(13%) 
 HD vintage (y) 2.7±3.7 
Graft survival (y) 7±6.6 
GFR (cockroft, ml/min) 65.6±24 
OSBP/ODBP (mmHg) 136(±14)/83(±12) 
HSBP/HDBP (mmHg) 135(±12)/82(±10) 
24-h SBP/24-h DBP (mmHg) 133(±10)/80(±9) 
MASKED HYPERTENSION IS ASSOCIATED WITH A HIGH CARDIOVASCULAR RISK IN 
HYPERTENSIVE KIDNEY TRANSPLANT RECIPIENTS 
P. Xhignesse, A. Saint-Remy, B.Dubois, C. Bonvoisin, L. Weekers and JM. Krzesinski 
Nephrology-Hypertension Unit- University Hospital of Liege-Belgium 
Antihypertensives drugs 
mean number 2.1±1.0 (1-5) 
Diuretics 21 (30%) 
Beta-blockers 48 (68%) 
CCB 35 (50%) 
ACE 21 (30%) 
ARB 14 (20%) 
centrally acting 9 (13%) 
Objective: 
High blood pressure (BP) is a major risk factor 
for graft function in kidney transplant recipients 
(KTs) Our aim was to evaluate BP control in the 
office, but also in the ambulatory and home 
settings, in stable KTs, all treated for 
hypertension, and to characterize patients with 
masked hypertension (MHT). 
Methods: 
3 BP measurement techniques: Office blood 
pressure, sitting position; 24-h ambulatory BP 
monitoring (discriminating day and night periods) 
Spacelabs 90207; 7 days recording of  home 
BP(HBP) monitoring (OMRON M6), 2 BP morning/2 
BP evening. 
Carotid-femoral pulse wave velocity was measured 
(SphygmoCor) as well as a calcification score 
(arteries) and the systolic ankle brachial index (ABI) 
as recommended. 
MHT NT P* 
men/women 12/3 10/8 








HD vintage (months) 23.8±16.5 48.2±82.7 0.328 
Graft survival (years) 8.5±9 5.3±4 0.33 
GFR(ml/min) 74.4±23.2 62.3±26.1 0.17 
CRP(mg/l) 2.4±2.6 3.1±4.9 0.6 
Antihypert. Drugs (n) 2±1 2.2±1 0.69 
OSBP  (mmHg) 130±6 125±10 0.092 
    ODBP  (mmHg) 79±7 75±10 0.21 
HPAS (mmHg) 138±6.4 123±9 <0.0001 
HPAD (mmHg) 83±7.4 74±8.4 0.004 
Day PAS (ABPM) 134±6.2 127±8.3 0.009 
Ca score 6.3±5.0 2.2±4.1 0.043 
PWV (m/s) 9.7±3.0 7.9±1.6 0.03 
Results:   
Uncontrolled hypertension (HTN) remained 
frequent in our treated population, 46 % were 
still hypertensive in the office, 39% using ABPM  
and 43% with HBP. The proportion of MHT was 
22% whatever the out-of-clinic method used, 
with more males, older and more overweight. 
Interestingly when compared with controlled KTs 
(i.e both OBP and Daytime ABP controlled or 
both OBP and HBP controlled), patients with 
MHT had significantly higher PWV, a higher 
calcification score (x ray) and a higher rate of  
ABI>1.3 (on graph) corresponding to stiff 
arteries .  
However we did not find any significant impact 
of graft survival, GFR, CRP, smoking habits, 
diabetes, alcohol use or immunosuppressive 
drugs although MHT patients were more 
frequently treated with cyclosporine.  
Conclusion: 
A high percentage of uncontrolled HTN was 
noted by OBP, but also by ABPM and HBP 
despite antihypertensive treatment. MHT was 
frequently observed in KTs. This particular HT 
phenotype, either defined by OBP vs ABPM or 
by OBP vs HBP, was significantly associated 
with major markers of arterial stiffness.   
So,our observations support that in KTs masked 
hypertension is obviously associated with a high 
cardiovascular risk profile.  
Ambulatory BP measurements (24-h or/and 
home BP) are necessary to identify such 
patients allowing a treatment adaptation to 
reduce incidence of cv events and graft loss. 
Characteristics NT/MHT % 
* U Mann-Whitney test 
